FDA Announces Recall of Hair Loss Medication

According to a statement published by the U.S. Food and Drug Administration on May 11, 2020, 1 lot of Finasteride Plus 1.25 mg, a medication designed to treat hair loss, is being recalled by its manufacturer MasterPharm, LLC. The recall is due to the medication containing undeclared amounts of minoxidil, which exceed those found in other FDA-approved products that contain the substance.

Minoxidil was originally developed as a medication to treat high blood pressure. It was later discovered to regrow hair in patients and was marketed as a topical hair loss treatment called Rogaine. People who take high levels of minoxidil, especially orally, are at risk of suffering serious side effects, including:

  • Low blood pressure
  • Rapid heartbeat
  • Salt and water retention
  • Swelling
  • Increased risk of heat failure and other heart damage
  • Excess fluid buildup between heart and sac surrounding the heart

The recalled product is a compounded drug and is shipped in orange prescription pill bottles containing 30 capsules. Another affected lot ships in blue prescription bottles containing 90 capsules. People who purchased the medication are being notified by MasterPharm, LLC., via phone, email, and letters, and they can return and replace their affected pills.

At Ferrer, Poirot & Wansbrough, we’re always on the lookout for potential drug recalls that can harm innocent people. It’s important to stay up to date on possible recalls, but to also talk to your doctor when they affect a medication you take. Never stop taking a medication without first consulting your doctor. And if you or someone you love was injured by a dangerous drug, our drug injury lawyers are standing by to speak with you.